Back
Criteo SA Vs. Denali Therapeutics Industry Stock Comparison
Sell
26
CRTO
Criteo SA
Last Price:
35.44
Seasonality Move:
4.95%
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
Sell
26
Criteo SA (CRTO)
is a Sell
Is Criteo SA a Buy, Sell or Hold?
- The current Criteo SA [CRTO] share price is $35.47. The Score for CRTO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- CRTO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRTO Stock Price Chart
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRTO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.83 | Sell |
| Relative Strength Index (14 RSI): | 37.78 | Sell |
| Chaikin Money Flow: | 74017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.79 - 42.05) | Sell |
| Bollinger Bands (100): | (37.83 - 46.05) | Sell |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 68.76 | Buy |
| Chaikin Money Flow: | 648733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.03 - 28.61) | Buy |
| Bollinger Bands (100): | (22.45 - 28.23) | Buy |
CRTO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.53 | Buy |
| 20-day SMA: | 38.59 | Sell |
| 50-day SMA: | 40.8 | Sell |
| 200-day SMA: | 38.23 | Sell |
| 8-day EMA: | 35.81 | Sell |
| 20-day EMA: | 37.68 | Sell |
| 50-day EMA: | 39.96 | Sell |
| 200-day EMA: | 38.29 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.16 | Buy |
| 20-day SMA: | 27.44 | Buy |
| 50-day SMA: | 27.75 | Buy |
| 200-day SMA: | 22.07 | Buy |
| 8-day EMA: | 28.79 | Buy |
| 20-day EMA: | 27.93 | Buy |
| 50-day EMA: | 27.13 | Buy |
| 200-day EMA: | 23.94 | Buy |
Criteo SA Earnings Growth & CRTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.47 per share, and an increase next year of $0.15 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
Criteo SA Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||